Bio-Connect
Lane 1: EC9706 lysates; Lane 2: mouse lymph node lysates probed with IL2RA Polyclonal Antibody, Unconjugated (bs-0577R) at 1:500 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: EC9706 lysates; Lane 2: mouse lymph node lysates probed with IL2RA Polyclonal Antibody, Unconjugated (bs-0577R) at 1:500 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: EC9706 lysates; Lane 2: mouse lymph node lysates probed with IL2RA Polyclonal Antibody, Unconjugated (bs-0577R) at 1:500 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.

IL2RA/CD25 Polyclonal Antibody

BS-0577R
Bioss Antibodies
ApplicationsFlow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetIl2ra
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bioss Antibodies
  • Product Name
    IL2RA Polyclonal Antibody
  • Delivery Days Customer
    16
  • Applications
    Flow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    WB(1:300-5000), ELISA(1:500-1000), FCM(1:20-100), IHC-P(1:200-400)
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 ug/ul
  • Conjugate
    Unconjugated
  • Gene ID16184
  • Target name
    Il2ra
  • Target description
    interleukin 2 receptor, alpha chain
  • Target synonyms
    CD25; I; IL-2 receptor subunit alpha; Il2r; IL-2R alpha chain; IL-2R subunit alpha; IL-2-RA; IL2-RA; interleukin-2 receptor subunit alpha; Ly-4; Ly-43; p55 chain
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP01590
  • Protein Name
    Interleukin-2 receptor subunit alpha
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Sonodynamic therapy-assisted immunotherapy: A novel modality for cancer treatment. Zhang Q et al., 2018 May, Cancer Sci
    Read more